Tech Company Financing Transactions
Avila Therapeutics Funding Round
Avila Therapeutics closed a $30 million Series B funding round on 7/27/2009. Backers included Novartis Venture Fund, Abingworth and Advent Venture Partners.
Transaction Overview
Company Name
Announced On
7/27/2009
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
Novartis Venture Fund (Lead Investor) (Nagesh Mahanthappa)
Proceeds Purpose
The new financing will be used to move Avila's first program into clinical trials, while also advancing the Avilomics drug discovery approach, the company said.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
45 Wiggins Ave.
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Website
Email Address
Overview
Avila Therapeutics, Inc., is a venture-backed company focused on the discovery and development of novel small molecule therapeutics to address significant unmet clinical needs with an initial focus on cancer and viral diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Katrine Bosley
Chief Scientific Officer
Juswinder Singh
VP - Operations
Nagesh Mahanthappa
Browse more venture capital transactions:
Prev: 7/27/2009: Suniva venture capital transaction
Next: 7/27/2009: FRX Polymers venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs